Human T-cell leukemia virus-1 (HTLV-1) is a neglected and incurable retrovirus estimated to
infect 5 to 10 million worldwide. Specific indigenous Australian populations report infection …

Abstract Background The Human T-cell Lymphotropic Virus Type-1 (HTLV-1) is a blood-
borne pathogen and etiological agent of Adult T-cell Leukemia/Lymphoma (ATLL) and HTLV …

Human T-cell lymphotropic virus type 1 (HTLV-1) infects 5–10 million people worldwide and
is the causative agent of adult T-cell leukemia/lymphoma (ATLL) and HTLV-1-associated …

The virus HTLV-1 is thought to pass between cells through synapses formed when infected
lymphocytes make contact with other T cells. Isabelle Thoulouze and her colleagues …

Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia
and HTLV-1-associated myelopathy/tropical spastic paraparesis. The HTLV-1 transactivator …

Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic human retrovirus that has
infected 10–15 million people worldwide. After a long latency, 3–5% of infected individuals …

Human T-cell leukaemia virus type 1 (HTLV-1) causes not only adult T-cell leukaemia-
lymphoma (ATL), but also inflammatory diseases including HTLV-1-associated …

The deltaretroviruses human T cell lymphotropic virus type 1 (HTLV-1) and human T cell
lymphotropic virus type 2 (HTLV-2) have long been believed to differ from retroviruses in …

The tumorvirus human T-cell lymphotropic virus type 1 (HTLV-1), a member of the delta-
retrovirus family, is transmitted via cell-containing body fluids such as blood products …

Background HTLV-1 infects over 20 million people worldwide and causes a progressive
neuroinflammatory disorder in a subset of infected individuals called HTLV-1 associated …